Skip to main content

GENERAL COMMENTARY article

Front. Pharmacol., 09 February 2015
Sec. Experimental Pharmacology and Drug Discovery
Volume 6 - 2015 | https://doi.org/10.3389/fphar.2015.00018
This article is part of the Research Topic Transporters, physiology, efflux inhibition and the challenge of clinical implementation View all 9 articles

Corrigendum: The role of drug transporters in the kidney: lessons from tenofovir

This article is a commentary on:

  1. The role of drug transporters in the kidney: lessons from tenofovir

    1. Read original article
\r\nDarren M. Moss*Darren M. Moss*
  • Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK

A corrigendum on
The role of drug transporters in the kidney lessons from tenofovir

by Moss, D. M., Neary, M., and Owen, A. (2014). Front. Pharmacol. 5:248. doi: 10.3389/fphar.2014.00248

The authors wish to correct a mistake on the review “The role of drug transporters in the kidney: lessons from tenofovir” regarding the details of a particular ABCC2 polymorphism [−24C > T (rs717620)]. In the Section “Tenofovir and kidney transporter pharmacogenetics” on page five of the article, the second line on the second column should state the ABCC2 polymorphism as −24C > T, rather than −24T > C. Additionally, the sentence beginning on page five, line four of the second column should be changed from: “In a study in Japanese HIV+ patients, the ABCC2 −24C > T and1249G > A polymorphisms were found to be protective for tenofovir-induced kidney toxicity (Nishijima et al., 2012).” and instead read: “In a study in Japanese HIV+ patients, the ABCC2 −24T > C and 1249G > A polymorphisms were found to be associated with the increased occurrence of tenofovir-induced kidney toxicity (Nishijima et al., 2012).”

Conflict of Interest Statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

Nishijima, T., Komatsu, H., Higasa, K., Takano, M., Tsuchiya, K., Hayashida, T., et al. (2012). Single nucleotide polymorphisms in ABCC2 associate with tenofovirinduced kidney tubular dysfunction in Japanese patients with HIV-1 infection: a pharmacogenetic study. Clin. Infect. Dis. 55, 1558–1567. doi: 10.1093/cid/cis772

Pubmed Abstract | Pubmed Full Text | CrossRef Full Text | Google Scholar

Keywords: tenofovir, HIV-1, drug transporters, kidney, toxicity

Citation: Moss DM (2015) Corrigendum: The role of drug transporters in the kidney: lessons from tenofovir. Front. Pharmacol. 6:18. doi: 10.3389/fphar.2015.00018

Received: 22 December 2014; Accepted: 20 January 2015;
Published online: 09 February 2015.

Edited by:

George Tegos, Massachusetts General Hospital, USA

Reviewed by:

Olaf Grisk, University of Greifswald, Germany

Copyright © 2015 Moss. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence:ZGFycmVuLm1vc3NAbGl2ZXJwb29sLmFjLnVr

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.